Canada markets closed

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0490-0.0040 (-7.55%)
At close: 03:43PM EST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-119,916
-205,192
-142,309
-80,033
Depreciation & amortization
1,050
1,023
302
263
Stock based compensation
4,480
8,898
12,697
8,579
Change in working capital
16,007
10,578
-15,227
-12,673
Accounts receivable
-8,732
-5,382
-1,067
-
Inventory
4,382
-21
-6,010
-
Accounts Payable
7,292
-4
4,126
-2,931
Other working capital
-85,503
-149,606
-107,083
-55,261
Other non-cash items
2,521
4,069
2,940
642
Net cash provided by operating activites
-85,144
-146,667
-104,829
-55,097
Cash flows from investing activities
Investments in property, plant and equipment
-359
-2,939
-2,254
-164
Purchases of investments
-
-
0
-8,233
Sales/Maturities of investments
-
0
8,233
-
Net cash used for investing activites
-359
-2,689
6,229
-8,115
Cash flows from financing activities
Debt repayment
-
-
0
-4,010
Common stock issued
32,320
81,534
107,519
78,360
Dividends Paid
-
-
-
0
Other financing activites
-1,437
-1,297
-3,742
-2,852
Net cash used privided by (used for) financing activities
70,305
90,693
154,226
78,076
Net change in cash
-15,198
-58,663
55,626
14,864
Cash at beginning of period
25,040
72,251
16,625
1,761
Cash at end of period
9,842
13,588
72,251
16,625
Free Cash Flow
Operating Cash Flow
-85,144
-146,667
-104,829
-55,097
Capital Expenditure
-359
-2,939
-2,254
-164
Free Cash Flow
-85,503
-149,606
-107,083
-55,261